Hua Medicine-B announced on 23 April 2026 that the English and Chinese versions of its 2025 Annual Report, together with an accompanying circular and proxy form for the upcoming annual general meeting (AGM), have been released on both the company’s website (www.huamedicine.com) and the HKEX platform (www.hkexnews.hk).

The circular outlines five key AGM proposals: 1. Re-election of retiring directors. 2. Granting of general mandates to repurchase and issue shares. 3. Re-appointment of the external auditor. 4. Adoption of a new Memorandum and Articles of Association. 5. Approval of the AGM notice and related procedural matters.

Non-registered shareholders holding shares through banks, brokers, custodians or HKSCC Nominees may access the documents electronically or request free printed copies. To obtain hard copies—available in English, Chinese or both—shareholders must complete the enclosed request form and return it to the Hong Kong branch share registrar, Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid mailing label or via email (2552-ecom@vistra.com).

Printed-copy requests will remain valid until 31 December 2028 unless amended in writing. Enquiries can be directed to Tricor’s hotline at +852 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding public holidays).